跳至主要内容
临床试验/PACTR201710002161189
PACTR201710002161189Other未知

Comparative Study between the Effect of Dexmedetomidine versus Nalbuphine as an Adjuvant to Bupivacaine in Paravertebral Block in Breast Cancer Surgery

Faculty of Medicine Fayoum University0 个研究点目标入组 60 人开始时间: 2017年3月31日最近更新:
适应症

试验速览

阶段
未知
状态
Other
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 78 Year(s)(—)
性别
Female

入选标准

  • ASA I, II, III
  • female 18-78
  • breast cancer surgery

排除标准

  • Exclusion criteria included patients undergoing bilateral breast surgery or breast reconstruction; those having contra-indications for PVB, e.g., patient refusal, infection at injection site, anticoagulant therapy, abnormal coagulation profile, or hypersensitivity to LA; patients on chronic antiemetics or chronic pain medication; pregnant patients; central neuropathy, liver or renal impairment, drug or alcohol abusers, and those with psychiatric illnesses that would interfere with perception and assessment of pain and obese patients with a body mass index (BMI) >30 kg/m2.

研究者

发起方
Faculty of Medicine Fayoum University

相似试验